TSXV:WL

Stock Analysis Report

Executive Summary

Westleaf Inc. engages in the cultivation, extraction, distribution, and sale of cannabis and cannabis related products.

Snowflake

Fundamentals

Fair value with mediocre balance sheet.

Risks

  • Westleaf has significant price volatility in the past 3 months.
  • Westleaf is covered by less than 3 analysts.

Share Price & News

How has Westleaf's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-9.1%

TSXV:WL

-6.0%

CA Pharmaceuticals

-1.2%

CA Market


1 Year Return

n/a

TSXV:WL

-22.8%

CA Pharmaceuticals

-4.6%

CA Market

No trading data on WL.

No trading data on WL.


Share holder returns

WLIndustryMarket
7 Day-9.1%-6.0%-1.2%
30 Day-31.4%-10.0%-3.0%
90 Day-44.4%-30.2%-3.3%
1 Yearn/a-22.4%-22.8%-1.2%-4.6%
3 Yearn/a382.2%380.3%13.5%3.5%
5 Yearn/a367.1%367.1%12.2%-3.5%

Price Volatility Vs. Market

How volatile is Westleaf's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Westleaf undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Westleaf's share price is below the future cash flow value, and at a moderate discount (> 20%).

Westleaf's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Westleaf is loss making, we can't compare its value to the CA Pharmaceuticals industry average.

Westleaf is loss making, we can't compare the value of its earnings to the Canada market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Westleaf, we can't assess if its growth is good value.


Price Based on Value of Assets

Westleaf is good value based on assets compared to the CA Pharmaceuticals industry average.


Next Steps

Future Growth

How is Westleaf expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

41.3%

Forecasted annual revenue growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Westleaf's revenue is expected to grow significantly at over 20% yearly.

Unable to determine if Westleaf is high growth as no earnings estimate data is available.

Westleaf's revenue growth is expected to exceed the Canada market average.

Unable to compare Westleaf's earnings growth to the Canada market average as no estimate data is available.

Unable to compare Westleaf's earnings growth to the low risk savings rate as no estimate data is available.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Westleaf will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Westleaf performed over the past 5 years?

-600.2%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Westleaf does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.

Unable to compare Westleaf's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Westleaf's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Westleaf has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Westleaf has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Westleaf improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Westleaf's financial position?


Financial Position Analysis

Westleaf is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Westleaf's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Westleaf's level of debt (4.4%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Westleaf's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 5.8x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Westleaf has less than a year of cash runway based on current free cash flow.

Westleaf has less than a year of cash runway if free cash flow continues to grow at historical rates of 130.6% each year.


Next Steps

Dividend

What is Westleaf's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Westleaf's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Westleaf's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Westleaf has not reported any payouts.

Unable to verify if Westleaf's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Westleaf has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Westleaf's salary, the management and board of directors tenure and is there insider trading?


CEO

Scott Hurd 0

0.0yrs

Tenure

0

Mr. Scott Hurd is the Founder, President, Chief Executive Officer & Director of Westleaf Inc. He has significant leadership, business development, and principal investing / capital markets expertise. Prior ...


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Pat Whelan

    Founder & Executive VP

    • Tenure: 0.0yrs
  • Taylor Ethans

    Founder

    • Tenure: 0.0yrs
  • Steve Mason

    Founder & Executive Chairman

    • Tenure: 0.0yrs
  • Scott Hurd

    Founder

    • Tenure: 0.0yrs
  • Ben Kaanta

    Chief Operating Officer

    • Tenure: 0.0yrs
  • Christian Monson

    Chief Legal Officer & VP of Strategy

    • Tenure: 0.0yrs
  • Brian Krywulak

    Vice President of Finance & Accounting

    • Tenure: 0.0yrs
  • Bruce Leslie

    Vice President of Corporate Communications

    • Tenure: 0.0yrs
  • Stuart Boucher

    Director of Corporate Development & Strategy

    • Tenure: 0.6yrs
  • Petra Shim

    Director of Marketing

    • Tenure: 0.3yrs

Board Members

  • Cody Church (48yo)

    Director

    • Tenure: 0.1yrs
  • Robb McNaughton (48yo)

    Director

    • Tenure: 0.0yrs
  • Steve Mason

    Founder & Executive Chairman

    • Tenure: 0.0yrs
  • Kareen Stangherlin

    Director

    • Tenure: 0.0yrs
  • Delbert Wapass

    Director

    • Tenure: 0.0yrs
  • Scott Hurd

    Founder

    • Tenure: 0.0yrs
  • John Radostits

    Director

    • Tenure: 0.3yrs

Company Information

Westleaf Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Westleaf Inc.
  • Ticker: WL
  • Exchange: TSXV
  • Founded:
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$49.866m
  • Shares outstanding: 142.47m
  • Website: https://www.westleaf.com

Number of Employees


Location

  • Westleaf Inc.
  • 517 – 10th Avenue SW
  • Suite 1000
  • Calgary
  • Alberta
  • T2R 0A8
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
WLTSXV (TSX Venture Exchange)YesCommon SharesCACADJan 2019
WSLF.FOTCPK (Pink Sheets LLC)YesCommon SharesUSCADJan 2019

Biography

Westleaf Inc. engages in the cultivation, extraction, distribution, and sale of cannabis and cannabis related products. The company is headquartered in Calgary, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/19 01:06
End of Day Share Price2019/08/16 00:00
Earnings2019/03/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.